Company Data
VYNE Therapeutics Inc.
Ticker
VYNE
Current Price
$1.16 -3.33%
Market Cap
$19.3M
Price Target
Refer to Report
Volume
694.9K
52wk Range
$0.85 - $4.3
Overview
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds.